What is CANVAS syndrome (Cerebellar Ataxia, Neuropathy and Vestibular Areflexia Syndrome) and how is it diagnosed and managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CANVAS Syndrome: Definition, Diagnosis, and Management

What is CANVAS Syndrome?

CANVAS (Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome) is a late-onset autosomal recessive neurodegenerative disorder caused by biallelic AAGGG repeat expansions in intron 2 of the RFC1 gene, presenting with the classic triad of progressive cerebellar ataxia, bilateral vestibular areflexia, and sensory neuropathy or neuronopathy. 1, 2

Core Clinical Features

The syndrome typically manifests in middle age with:

  • Progressive imbalance from combined cerebellar, proprioceptive, and vestibular system impairment 1, 3
  • Oscillopsia (visual blurring with head movement) due to bilateral vestibular loss 1
  • Sensory disturbance from sensory neuropathy or ganglionopathy 1, 4
  • Chronic dry cough that often precedes neurological symptoms by years and serves as a critical diagnostic clue 1, 3

Expanded Phenotypic Spectrum

Beyond the classic triad, CANVAS frequently includes:

  • Dysautonomia with blood pressure instability, bowel/bladder dysfunction 2, 4
  • Neurogenic pain (radicular or neuropathic) 4
  • Chronic cough present in the majority of cases 2, 4
  • Site-restricted variants affecting only sensory nerves, cerebellum, or vestibular system in isolation 1, 3

Diagnostic Approach

Clinical Examination Priorities

The key to diagnosis is systematic assessment of all three affected systems plus recognition of chronic cough. 1

Cerebellar System Assessment

  • Wide-based gait with truncal instability that does NOT worsen with eye closure (distinguishing from sensory ataxia) 5
  • Dysmetria on finger-to-nose and heel-to-shin testing 5
  • Dysdiadochokinesia and dyssynergia 5
  • Ataxic dysarthria with scanning speech 5
  • Ocular dysmetria (saccadic overshooting) 5

Vestibular System Assessment

  • Bilateral vestibular areflexia on bedside head impulse testing 1, 4
  • Impaired visuo-vestibulo-ocular reflex (VVOR) - a characteristic deficit due to impaired slow stabilizing eye movements 4
  • Oscillopsia reported during head movement 1

Sensory Neuropathy Assessment

  • Sensory neuropathy or neuronopathy with distal sensory loss 1, 4
  • Decreased or absent reflexes (areflexia) 4
  • Proprioceptive deficits contributing to imbalance 3
  • Neuropathological studies demonstrate diffuse ganglionopathy affecting both sensory and vestibular systems 4

Associated Features to Document

  • Chronic cough - ask specifically about this symptom as it often precedes neurological manifestations 1, 3
  • Dysautonomia signs (orthostatic symptoms, bowel/bladder changes) 2, 4
  • Pain patterns (neuropathic, radicular) 4

Genetic Testing

RFC1 genetic testing for biallelic AAGGG repeat expansions is the definitive diagnostic test. 1, 2

Genetic Findings

  • Biallelic (AAGGG)n expansions in RFC1 intron 2 are found in 100% of familial cases and 92% of sporadic cases with complete triad 4
  • Alternative pathogenic expansion (ACGGG)n also causes CANVAS 3
  • Truncating variants in RFC1 coding region (e.g., c.1267C>T, c.2876del) can occur in trans with (AAGGG)n expansion 6
  • Full RFC1 sequencing is recommended in typical CANVAS cases carrying only monoallelic (AAGGG)n expansions to detect second truncating variants 6

Pathomechanism

  • Pathogenic expansions disrupt RFC1 function via secondary structures (G-quadruplexes) 2
  • Truncating variants cause nonsense-mediated mRNA decay with reduced RFC1 transcript and protein, supporting a loss-of-function mechanism 6

Neuroimaging

MRI of the head without IV contrast is the preferred initial imaging modality. 5, 7

Expected MRI Findings

  • Cerebellar atrophy affecting hemispheres and vermis 5, 7
  • Signal abnormalities in cerebellum and brainstem 5
  • Early imaging may be normal or subtly abnormal, with progressive changes on follow-up 7

Additional Imaging Considerations

  • MRI of cervical and thoracic spine should be obtained when spinal cord signs (motor spasticity, sensory ataxia) are present to evaluate for spinal cord atrophy 7
  • Spine imaging helps exclude alternative diagnoses and may show cord atrophy correlating with symptom severity 7

Differential Diagnosis

Key Distinguishing Features

  • Negative Romberg test (unsteadiness does NOT worsen with eye closure) distinguishes CANVAS from sensory ataxia 5, 8
  • Bilateral vestibular areflexia distinguishes from other spinocerebellar ataxias 1, 4
  • Chronic cough is highly specific and not typical of other ataxias 1, 3

Conditions to Exclude

  • Other spinocerebellar ataxias (SCA1-48, Friedreich ataxia) - typically lack vestibular areflexia and chronic cough 7
  • Miller Fisher syndrome - presents with ataxia, areflexia, and ophthalmoplegia (not vestibular areflexia), acute/subacute onset 9, 7
  • Posterior circulation stroke - acute onset, not progressive 7
  • Cerebellar tumors - must be excluded with imaging 7
  • Inflammatory/paraneoplastic cerebellar degeneration - different tempo and associated features 9, 7

Clinical Epidemiology

RFC1 disease is probably the most common cause of recessive ataxia. 1

  • Typical onset in middle age (40s-60s) 1, 2
  • Slowly progressive course over years to decades 1, 2
  • Autosomal recessive inheritance pattern 2, 4
  • Phenotypic spectrum expanding to include isolated neuronopathy, cerebellar-only, or vestibular-only presentations 1, 3

Management

Current Treatment Limitations

There is no disease-modifying therapy for CANVAS; management is entirely supportive and rehabilitative. 1, 2

Rehabilitation Strategies

Based on general cerebellar ataxia management principles:

  • Balance training programs to improve stability 5
  • Postural training for trunk control 5
  • Task-oriented upper limb training for reaching and fine motor control 5
  • Assistive devices and orthoses (canes, walkers) to improve balance and mobility 5

Symptomatic Management

  • Chronic cough management (though specific effective therapies not well-established) 1, 2
  • Neuropathic pain treatment with standard agents 4
  • Dysautonomia management (orthostatic hypotension measures, bowel/bladder support) 2, 4

Monitoring

  • Serial neurological examinations to track progression 1, 2
  • Follow-up MRI may demonstrate progressive cerebellar atrophy 7

Critical Diagnostic Pitfalls

  • Missing chronic cough as a diagnostic clue - always ask about this symptom specifically 1, 3
  • Failing to test vestibular function - bilateral vestibular areflexia is essential for diagnosis 1, 4
  • Assuming all progressive ataxia is benign hereditary disease - always exclude tumors, inflammatory conditions, and paraneoplastic syndromes first 7
  • Stopping genetic testing after finding monoallelic RFC1 expansion - proceed to full RFC1 sequencing to detect truncating variants 6
  • Overlooking site-restricted phenotypes - isolated sensory neuropathy or cerebellar ataxia may be RFC1-related 1, 3

References

Research

[RFC1 CANVAS/Spectrum Disorder: Historical Details and Clinical Diversity].

Brain and nerve = Shinkei kenkyu no shinpo, 2022

Guideline

Cerebellar Ataxia Diagnosis and Examination Findings

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Cerebellar Ataxia Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Spinocerebellar Ataxia Type 14 (SCA14) Diagnostic Approach and Clinical Features

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.